Search company, investor...

Spiracur

spiracur.com

Stage

Debt | Dead

Total Raised

$71.3M

Last Raised

$16M

About Spiracur

Spiracur is a privately held medical device company focused on the development of innovative wound healing technologies. Its first product, the SNaP Wound Care System for the treatment of chronic and acute wounds, is the result of patient and clinician feedback that current negative pressure wound therapies were too cumbersome. The company's ciSNaP Closed Incision System with proprietary controlled tension relief is designed to improve healing of high-risk surgical incisions. Both devices have received 510(k) clearance from the U.S. Food & Drug Administration (FDA) and have received CE Mark approval. Spiracur's proprietary mechanically powered technology does not require batteries or electricity to operate.

Headquarters Location

1180 Bordeaux Drive

Sunnyvale, California, 94089,

United States

408-701-5300

Missing: Spiracur's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Spiracur's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Spiracur

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Spiracur is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Spiracur Patents

Spiracur has filed 31 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/14/2014

9/1/2020

Fluid dynamics, Matrix metalloproteinases, Medical treatments, Medical equipment, EC 3.4.24

Grant

Application Date

3/14/2014

Grant Date

9/1/2020

Title

Related Topics

Fluid dynamics, Matrix metalloproteinases, Medical treatments, Medical equipment, EC 3.4.24

Status

Grant

Latest Spiracur News

Advanced Wound Care Market – SWOT Analysis of Major Industry Segments

Jan 7, 2020

A new research study from “Data Bridge Market Research”  with title Advanced Wound Care Market Insights 2020, Global  Analysis and Forecast to 2027 provides an in-depth assessment of the Advanced Wound Care Market  including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. Some of the leading key players profiled in this study: 3M,Smith and Nephew,Medtronic,Acelity L.P. INC,Molnlycke Healthcare AB,Convatec Inc,Baxter,Coloplast,Inc,Hollister Inc,Integra Life Sciences Corporation,Derma Sciences Inc,Spiracur Inc,Medline Industries,Mimedx Group,Organogenesis Inc,Talley Group,BSN Medical   Global  advanced wound care  is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a stronger CAGR of 4.4% in the forecast period of 2020 to 2027. This Press Release will help you to understand the Overview, growth, Application with Impacting Trends. Click here To get Sample Analysis of Report  at @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market Market Definition:   Rising aging population, growing incidences of diabetes, technological advancement, rising awareness regarding new technology, government support in the terms of funding, reduced the duration of hospital stays, rising incidence of chronic wounds, problem associated with ineffective traditional wound healing method, increase funding in wound care and development, increasing volume of surgeries across the globe, faster recovery and healing time, range of wound indications at relatively lower prices, innovative products and rising demand in emerging healthcare market are some of the drivers contributing to the growth of the market   Market Segmentation: Global Advanced Wound Care Market Advanced wound care market is segmented of the basis of product type, therapy devices, type of dressings, wound type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets By Type (Dressings, Biologics, Therapy Devices) Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds) End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare) Distribution Channel (Direct Tenders Public, Retail Private) Key vendors operating in the Market: Some of the Prominent Players in the Advanced Wound Care Market are:- 3M North America Focal points covered in this Advanced Wound Care Market report This  Global Advanced Wound Care Market  report provides pin point analysis of the market outlook and later establishes its comparison with current patterns. Also it creates a relationship of the market outlook with Porter Five Force Analysis This research report is inclusive concept of the market progression. The market progression considers the components of the present situation and compares the current scenario of the market with future developmental chances. The Advanced Wound Care Market research report includes investigation at global and regional levels. These comprehensive and local level investigations are inclusive of the request as well as the supply powers which in turn willingly or unwillingly affects the market development Various Topics such as product offering, finance related data, recent developments, analysis of Strengths, weakness, Opportunities and Threats in the upcoming scenario are highlighted in this research report. Most important Highlights of TOC: 01: Executive Summary 03: Market Landscape

Spiracur Frequently Asked Questions (FAQ)

  • Where is Spiracur's headquarters?

    Spiracur's headquarters is located at 1180 Bordeaux Drive, Sunnyvale.

  • What is Spiracur's latest funding round?

    Spiracur's latest funding round is Debt.

  • How much did Spiracur raise?

    Spiracur raised a total of $71.3M.

  • Who are the investors of Spiracur?

    Investors of Spiracur include GE Capital, Kleiner Perkins Caufield & Byers, De Novo Ventures, New Leaf Venture Partners, Pinnacle Ventures and 3 more.

  • Who are Spiracur's competitors?

    Competitors of Spiracur include Tepha, Amsino International, Acelity, TransMedics, Paragon Medical and 12 more.

Compare Spiracur to Competitors

D
Daverci Solutions

Daverci Solutions aims to make electronic medication management systems for long-term care facilities and the institutional pharmacies that supply them.

Giltech Logo
Giltech

Giltech, a technology company based in Ayr on the West Coast of Scotland, has been at the forefront of controlled delivery and biodegradable technologies since it was founded in 1984. Giltech's initial focus was in the medical device area, where it has had a number of successes with wound care and urology products. Most notably, Giltech achieved international recognition through the successful development of Sorbsan, a wound dressing which is still marketed throughout the world.nGiltech is developing and customising its technologies to the stage where a particular product can be launched or subjected to commercial evaluation. To support this process the company operates its own in house development, engineering, computing and analytical facilities. Giltech has also invested in facilities to manufacture and process its own water soluble glasses, which aims to help protect the company's intellectual property in this area and provide ongoing support to the company's commercial activities.

N
NIR Diagnostics

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.

A
Aksys

Aksys has developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient's home.

Maroon Biotech Logo
Maroon Biotech

Maroon Biotech is developing polymeric surfactants for cell membrane sealing and protein chaperoning. Applications for these developments are in wound healing, disease treatment, and industrial and food protein processing.

A
Acacian Emergency Solutions

Acacian Emergency Solutions is developing a system that permits emergency medical personnel in ambulances to wirelessly transmit critical patient data to hospital emergency rooms in real time using existing cellular networks. This system substantially aims to improve patient care as the actions within a few minutes of an emergency can seriously affect a patient's future.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.